Speech-Language Pathologists in Boston, MA Accepting Medicare

250 Speech-Language Pathologists found. Showing 61 - 80

Elizabeth Louise Hoover, MS, CCC-SLP, BC-NCD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 Commonwealth Ave, Boston, MA 02215 Phone: 617-353-8967

Sara Ryans, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Boston, MA 02135 Phone: 617-254-3800

Rachel M Santiago, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Lo-367, Boston, MA 02115 Phone: 617-355-6460    Fax: 617-730-0611

Ms. Meghann Atkinson Ridley, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 740 East 7th Street, Unit 26, Boston, MA 02127 Phone: 207-749-9938

Olivia White Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 187 F St, Apt 2, Boston, MA 02127 Phone: 858-354-1413

Jenna Marie Swabowicz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 Amory St, Boston, MA 02130 Phone: 617-383-6522

Kelly Kathleen Poe, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 755 Washington St, Boston, MA 02111 Phone: 617-636-7242

Victoria Flormann Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 185 Pilgrim Rd, Voice, Speech, And Swallowing: Span Building, Rm #106, Boston, MA 02215 Phone: 617-632-7400

Juliet A Ochura, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 781-216-1139

Ms. Marie Kay Rimshaw, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Boylston St, Boston, MA 02116 Phone: 617-824-8312

Miss Sarah Marie Tremblay, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 346 Commonwealth Ave, Apt Bf, Boston, MA 02115 Phone: 617-650-0333

Terese Hammerle, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Fransic Street, Boston, MA 02115 Phone: 617-525-7226

Kaitlyn Ann Regan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 65 E India Row Apt 5a, Boston, MA 02110 Phone: 732-586-4206

Sabrina Mai Barkal, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000

Ms. Tanya Barbara Acosta, MA. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 818 E 5th St, Boston, MA 02127 Phone: 857-257-9081

Mrs. Meredith Bosley O'dea, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 830 Harrison Ave, 11th Floor, Boston, MA 02118 Phone: 617-638-8124

Joyce S Gordon, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 275 Cambridge St, 3rd Floor, Boston, MA 02114 Phone: 617-724-0768

Mrs. Laura Germaine O'donnell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Boylston St, Boston, MA 02116 Phone: 617-824-8440

Rachel Woodward, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 781-355-7727

Allison Ma Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000

News Archive

Acclaimed Pacific Shores Medical Group joins City of Hope

City of Hope, a world-renowned cancer research and treatment center, today announced that acclaimed Pacific Shores Medical Group has joined City of Hope.

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Repligen Corporation today announced that the Company has received three additional grants to support its research program to develop HDAC inhibitors for neurodegenerative diseases. Repligen has received $436,000 in research funding to support the ongoing development of histone deacetylase inhibitors for Friedreich's ataxia.

Kensey Nash 2011 first quarter decreases 14% to $17.0 million

Kensey Nash Corporation , a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its first quarter ended September 30, 2010.

Cedars-Sinai launches new clinical trial to study effects of cabozantinib in prostate cancer patients

Researchers at Cedars-Sinai have launched a new clinical trial to investigate the effects of a cancer-fighting drug therapy that has shown favorable outcomes in patients with advanced metastatic prostate cancer.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »